US2007269835A1PendingUtilityA1
Reagent for determining laminin 5 antigen in biological sample and assay method
Est. expiryAug 17, 2021(expired)· nominal 20-yr term from priority
G01N 33/5759C07K 16/18G01N 33/6893G01N 2333/7055G01N 2800/38
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of determining a laminin 5 antigen in a biological sample, comprising the steps of bringing an antibody reactive to a laminin 5 γ2 chain N-terminal fragment into contact with the biological sample; measuring a reaction of the antibody; and determining an amount of the laminin 5 antigen based on a measurement result of the reaction, as well as, a method of detecting a laminin 5-producing tumor cell, a method of examining acute respiratory distress syndrome and a method of evaluating malignancy of a malignant tumor based on the assay method.
Claims
exact text as granted — not AI-modified1 . A method of determining β4 integrin expression, comprising steps of:
bringing an antibody reactive to a laminin 5 into contact with a cell culture supernatant; measuring a reaction of the antibody; and determining an expression amount of a β4 integrin in the cell based on the measurement result of the reaction.
2 . The method of claim 1 , wherein the antibody is a monoclonal antibody produced from a cell deposited with an accession number selected from the group consisting of: FERM BP-8133, FERM BP-8134, FERM BP-8135, FERM BP-8136, FERM BP-8137, FERM BP-8140, and combinations thereof.Join the waitlist — get patent alerts
Track US2007269835A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.